Notice: This company has been marked as potentially delisted and may not be actively trading. NASDAQ:TCDA Tricida (TCDA) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock Analysis About Tricida Stock (NASDAQ:TCDA) 30 days 90 days 365 days Advanced Chart Ad DTIThe gold trades I'm making right nowBack in November, gold made a tiny move of 1.6%. But using a special type of gold trade, I saw a 141% gain in just a week. It happened again in March. Gold nudged up 1.2%. This time? A 104% overnight gain. And in June? A 1% gold move turned into a 74% gain in two weeks. Granted, there were smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now. There's a more lucrative way to play the gold market as we enter a new breakout period.It's all about catching what I call "Acceleration Cycles." Get Tricida alerts:Sign Up Key Stats Today's Range N/A50-Day Range$0.11▼$0.1952-Week Range N/AVolume31.13 million shsAverage Volume17.62 million shsMarket Capitalization$6.01 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewTricida, Inc. is a pharmaceutical company. It focuses on the development and commercialization of its product, TRC101, a non-absorbed, orally-administered polymer drug designed to treat metabolic acidosis in patients with chronic kidney disease. The company was founded by Gerrit Klaerner and Craig Jon Hawker on May 22, 2013 and is headquartered in South San Francisco, CA.Read More… The gold trades I'm making right now (Ad)Back in November, gold made a tiny move of 1.6%. But using a special type of gold trade, I saw a 141% gain in just a week. It happened again in March. Gold nudged up 1.2%. This time? A 104% overnight gain. And in June? A 1% gold move turned into a 74% gain in two weeks. Granted, there were smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now. There's a more lucrative way to play the gold market as we enter a new breakout period.It's all about catching what I call "Acceleration Cycles." Receive TCDA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Tricida and its competitors with MarketBeat's FREE daily newsletter. Email Address TCDA Stock News HeadlinesPatrick G Enright's Net WorthMay 5, 2024 | benzinga.comSierraConstellation Partners Receives Industry Recognition for Work with TricidaFebruary 6, 2024 | finance.yahoo.comDon’t Miss Out! Get 2 Hot AI Stocks for Under $10/Share 🚀Artificial Intelligence (AI) stocks are booming, and now is your chance to get in on the action — without breaking the bank! We’ve just uncovered 2 must-buy AI stocks trading for under $10/share, and they’re showing serious potential for growth.October 28, 2024 | Darwin (Ad)Tricida Inc (TCDAQ)January 13, 2024 | es.investing.comTricida, Inc. (TCDA) Stock Historical Prices & Data - Yahoo FinanceFebruary 14, 2023 | finance.yahoo.comFirm Retention Summary: Tricida Inc.February 3, 2023 | wsj.comTricida Announces Third Quarter 2022 Financial ResultsNovember 15, 2022 | finance.yahoo.comTricida Provides Strategic UpdateNovember 2, 2022 | finance.yahoo.comSee More Headlines TCDA Stock Analysis - Frequently Asked Questions How were Tricida's earnings last quarter? Tricida, Inc. (NASDAQ:TCDA) issued its earnings results on Monday, November, 8th. The company reported ($0.79) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.70) by $0.09. When did Tricida IPO? Tricida (TCDA) raised $175 million in an initial public offering on Thursday, June 28th 2018. The company issued 10,300,000 shares at a price of $16.00-$18.00 per share. Goldman Sachs, J.P. Morgan and Cowen acted as the underwriters for the IPO. What other stocks do shareholders of Tricida own? Based on aggregate information from My MarketBeat watchlists, some other companies that Tricida investors own include Sorrento Therapeutics (SRNE), Alibaba Group (BABA), NIO (NIO), Pfizer (PFE), Energy Transfer (ET), Teladoc Health (TDOC) and Sesen Bio (SESN). Company Calendar Last Earnings11/08/2021Today10/28/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNASDAQ:TCDA CUSIPN/A CIK1595585 Webwww.tricida.com Phone(415) 429-7800FaxN/AEmployees57Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($2.36) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-176,570,000.00 Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-103.81% Debt Debt-to-Equity RatioN/A Current Ratio4.87 Quick Ratio4.87 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares55,670,000Free Float35,851,000Market Cap$6.01 million OptionableNot Optionable Beta0.22 A Beginner's Guide to Investing in CannabisUnlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.Get This Free Report This page (NASDAQ:TCDA) was last updated on 10/28/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredInvest in the company that won over the DragonsThe pioneer in smart-doorbell technology, RING, pitched their business on the hit show Shark Tank at a valuati...RYSE | SponsoredCountdown to Chaos begins WednesdayWill it be Trump or Harris? In an exclusive interview on Wednesday, October 30, at 8 p.m. ET, he’ll explain...Brownstone Research | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredCrypto Crash Ahead? (27 Experts Weigh In)27 of the world's brightest minds in crypto are gathering to reveal their top picks and predictions for the ma...Crypto 101 Media | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredTiny Defense Firm Set for Huge Gains with New US ContractOne tiny defense firm just won a groundbreaking US military contract… That could hand early investors gains...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tricida, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tricida With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.